Tenax Therapeutics, Inc.
TENXCIK 0000034956 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 10, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0088Δ-0.000293% similar+236/-215 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Tenax Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Doogan Declan | Director10% Owner | 4 |
| Hunter Robyn | Director | 4 |
| McGauley Thomas | Officer | 2 |
| Armistice Capital, LLC | Director | 1 |
| Armistice Capital Master Fund Ltd. | Director10% Owner | 1 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Tenax Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | McGauley Thomas | 3 | 100% | +69.8% | +69.8% | +69.8% | +69.8% |
| 2 | Almenoff June Sherie | 4 | 100% | +66.1% | +66.1% | +69.8% | +62.4% |
| 3 | Giordano Christopher Thomas | 3 | 100% | +65.0% | +62.4% | +70.5% | +62.2% |
| 4 | Rich Stuart | 5 | 100% | +20.0% | +24.3% | +29.0% | +7.0% |
All filings
42 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|